Author:
Samuel Nardin,Remke Marc,Rutka James T.,Raught Brian,Malkin David
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Clinical Neurology,Neurology,Oncology
Reference66 articles.
1. Howlader N, Noone AM, Krapcho M, Garshell J, Neyman N, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Cho H, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975–2010, National Cancer Institute. Bethesda, http://seer.cancer.gov/csr/1975_2010/ , based on November 2012 SEER data submission, posted to the SEER web site, December 2013
2. Astrakas LG, Zurakowski D, Tzika AA, Zarifi MK, Anthony DC, Girolami UD, Tarbell NJ, Black PM (2004) Noninvasive magnetic resonance spectroscoping imaging biomarkers to predict the clinical grade of pediatric brain tumors. Clin Cancer Res 10:8220
3. Rifai N, Gillette MA, Carr SA (2006) Protein biomarker discovery and validation: the long and uncertain path to clinical utility. Nat Biotechnol 24:971–983
4. van Dijk KD, Teunissen CE, Drukarch B, Jimenez CR, Groenewegen HJ, Berendse HW, van de Berg WD (2010) Diagnostic cerebrospinal fluid biomarkers for Parkin’s disease: a pathogenetically based approach. Neurobiol Dis 39(3):229–241
5. Nishizaki T, Kajiwara K, Adachi N, Tsuha M, Nakayama H, Ohshita N, Ikeda N, Ito H, Suzuki M (2001) Detection of craniospinal dissemination of intracranial germ cell tumors based on serum and cerebrospinal fluid levels of tumor markers. J Clin Neurosci 8(1):27–30
Cited by
35 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献